Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4440196
Max Phase: Preclinical
Molecular Formula: C54H87N3O15
Molecular Weight: 1018.30
Molecule Type: Unknown
Associated Items:
ID: ALA4440196
Max Phase: Preclinical
Molecular Formula: C54H87N3O15
Molecular Weight: 1018.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCN(C(=O)c1ccccc1)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C54H87N3O15/c1-15-24-57(51(65)35-20-18-17-19-21-35)38(50(64)55-54(8,9)10)27-36-26-31(4)39(58)23-22-30(3)25-37(29-68-53-49(67-14)48(66-13)45(62)34(7)70-53)41(16-2)71-42(60)28-40(59)32(5)47(36)72-52-46(63)43(56(11)12)44(61)33(6)69-52/h17-23,25,31-34,36-38,40-41,43-49,52-53,59,61-63H,15-16,24,26-29H2,1-14H3,(H,55,64)/b23-22+,30-25+/t31-,32+,33-,34+,36-,37-,38?,40-,41-,43+,44-,45+,46-,47-,48+,49+,52+,53+/m1/s1
Standard InChI Key: WGSHIQSHPYHLTM-MAFUACHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1018.30 | Molecular Weight (Monoisotopic): 1017.6137 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):